Shandong Boan Biotechnology Co (HKSE:06955) Accounts Payable & Accrued Expense : HK$330.1 Mil (As of Dec. 2023)

View and export this data going back to 2022. Start your Free Trial

What is Shandong Boan Biotechnology Co Accounts Payable & Accrued Expense?

Shandong Boan Biotechnology Co's quarterly accounts payable & accrued expense increased from Dec. 2022 (HK$226.3 Mil) to Jun. 2023 (HK$459.8 Mil) but then declined from Jun. 2023 (HK$459.8 Mil) to Dec. 2023 (HK$330.1 Mil).

Shandong Boan Biotechnology Co's annual accounts payable & accrued expense increased from Dec. 2021 (HK$214.1 Mil) to Dec. 2022 (HK$226.3 Mil) and increased from Dec. 2022 (HK$226.3 Mil) to Dec. 2023 (HK$330.1 Mil).

Shandong Boan Biotechnology Co Accounts Payable & Accrued Expense Historical Data

The historical data trend for Shandong Boan Biotechnology Co's Accounts Payable & Accrued Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Shandong Boan Biotechnology Co Accounts Payable & Accrued Expense Chart

Shandong Boan Biotechnology Co Annual Data

Trend

Dec20

Dec21

Dec22

Dec23

Accounts Payable & Accrued Expense

453.04

214.06

226.29

330.10

Shandong Boan Biotechnology Co Semi-Annual Data
	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23
Accounts Payable & Accrued Expense	Get a 7-Day Free Trial			214.06	170.15	226.29	459.76	330.10

Shandong Boan Biotechnology Co Accounts Payable & Accrued Expense Calculation

Accounts payable & accrued expense usually includes accounts payable, accrued compensation and related benefits, etc.

Accounts payable is money owed by a business to its suppliers shown as a liability on a company's balance sheet. It is distinct from notes payable liabilities, which are debts created by formal legal instrument documents.

It is part of the current portion of the liabilities (due within one year or within the normal operating cycle if longer) reflected on the balace sheet of the company. A higher Accounts Payable means lower Working Capital needed to operate the business.

Shandong Boan Biotechnology Co (HKSE:06955) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Shandong Boan Biotechnology Co Ltd (HKSE:06955) » Definitions » Accounts Payable & Accrued Expense

Comparable Companies

Traded in Other Exchanges

UJ9:Germany

Address

No. 39 Keji Avenue, High-Tech Industrial Development Zone, Shandong Province, Yantai, CHN

Website

https://www.boan-bio.com

Shandong Boan Biotechnology Co Ltd is a fully integrated biopharmaceutical company. The company is engaged in the development, manufacture, and commercialization of high-quality biologics in China and around the world. It focuses on areas such as oncology, metabolism, autoimmunity, and ophthalmology. Geographically company's revenue is generated from customers located in Mainland China.

Executives

Asiapharm Investments Ltd.
Ginkgo (ptc) Limited
Liu Dianbo
Luye Life Sciences Group Ltd
Luye Pharma Holdings Ltd.
Luye Pharma Hong Kong Limited
Luye Pharmaceutical International Co., Ltd.
Luye Pharmaceutical Investment Co., Ltd.
Nelumbo Investments Limited
Shorea Lbg
Luye Pharma Group Ltd.
Shan Dong Lv Ye Zhi Yao You Xian Gong Si
Yan Tai Lv Ye Yi Yao Kong Gu Ji Tuan You Xian Gong Si
Li Li	2201 Interest of corporation controlled by you

Shandong Boan Biotechnology Co (HKSE:06955) Headlines

No Headlines